Direct-acting antivirals improve liver transplant survival, impact wait-list composition
from The Clinical Advisor
The use of direct-acting antivirals (DAA) is associated with significant improvements in survival in patients undergoing liver transplantation because of hepatitis C virus (HCV)-related liver disease and decreased the number of patients with HCV needing liver transplantation, according to a study published in the Journal of Hepatology.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063